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Abstract. 
 
Excess nitric oxide (NO) induces apoptosis 
of some cell types, including macrophages. As NO is 
synthesized by NO synthase (NOS) from arginine, a 
common substrate of arginase, these two enzymes com-
pete for arginine. There are two known isoforms of ar-
ginase, types I and II. Using murine macrophage-like 
RAW 264.7 cells, we asked if the induction of arginase 
II would downregulate NO production and hence
prevent apoptosis. When cells were exposed to li-
 
popolysaccharide (LPS) and interferon-
 
g
 
 (IFN-
 
g
 
), the 
inducible form of NOS (iNOS) was induced, produc-
tion of NO was elevated, and apoptosis followed. When 
dexamethasone and cAMP were further added, both 
iNOS and arginase II were induced, NO production 
was much decreased, and apoptosis was prevented. 
When the cells were transfected with an arginase II ex-
pression plasmid and treated with LPS/IFN-
 
g
 
, some 
cells were rescued from apoptosis. An arginase I ex-
pression plasmid was also effective. On the other hand, 
transfection with the arginase II plasmid did not pre-
vent apoptosis when a NO donor SNAP or a high con-
centration (12 mM) of arginine was added. These re-
sults indicate that arginase II prevents NO-dependent 
apoptosis of RAW 264.7 cells by depleting intracellular 
arginine and by decreasing NO production.
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1. 
 
Abbreviations used in this paper:
 
 carboxy-PTIO, 2-(4-carboxyphenyl)-
 
4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide; Dex, dexamethasone; IFN-
 
g
 
,
interferon-
 
g
 
; iNOS, inducible NO synthase; LPS, lipopolysaccharide; NO,
 
nitric oxide; NOS, NO synthase; SNAP, 
 
S
 
-nitroso-
 
N
 
-acetyl-
 
DL
 
-penicil-
lamine.
 
N
 
ITRIC
 
 oxide (NO)
 
1
 
 is an important multifunctional
biomolecule involved in a variety of physiological
and pathological processes, including regulation
of blood vessel dilatation and immune response, and func-
tions as a neurotransmitter (Christopherson and Bredt,
1997; Harrison, 1997; Mayer and Hemmens, 1997; Nathan,
1997). In pathologic processes, NO functions as a bacteri-
cidal or tumoricidal agent; however, excess NO produc-
tion is thought to be the cause of several diseases, such as
septic shock (Stuehr and Marletta, 1985), autoimmune dis-
 
ease (Farrell et al., 1992), cerebral infarction (Dawson et al.,
 
1996), and diabetes mellitus (Corbett and McDaniel, 1992).
NO-mediated apoptosis is often observed in such cases
(Krncke et al., 1997). NO has several cytotoxic effects, in-
cluding reactions with proteins and nucleic acids. The
main targets of NO in proteins are the SH group (Molina y
Vedia et al., 1992) and Fe of active sites (Hibbs et al., 1988),
 
especially Fe
 
2
 
1
 
 (Kim et al., 1995) in heme. In the nucleus,
NO has been shown to cause mutations of genes (Rout-
ledge et al., 1994; Juedes and Wogan, 1996), and inhibition
of DNA repair enzymes (Kwon et al., 1991; Lepoivre et
al., 1991), and to mediate DNA strand breaks (Nguyen et
al., 1992; Fehsel et al., 1993). In several types of cells in-
cluding macrophages (Albina et al., 1993; Sarih et al.,
1993), chondrocytes (Blanco et al., 1995), neurons (Bon-
foco et al., 1995), and islet 
 
b
 
 cells (Kaneto et al., 1995), NO
has been shown to mediate apoptosis (Dimmeler and
Zeiher, 1997).
Morphologically, chromatin condensation, nuclear frag-
mentation, and formation of apoptotic body are character-
istic changes of apoptosis (Kerr, 1995). In the cascade of
inducing these morphological changes, IL-1
 
b
 
Ðconverting
enzyme (ICE)-like proteases or caspases play a key role
(Miura et al., 1993; Nicholson et al., 1995). Activation of
caspases leads to activation of a specific endonuclease
(Enari et al., 1998). Digestion of DNA at the linker por-
tions of nucleosomes by endonuclease causes fragmenta-
tion of DNA (Gaido and Cidlowski, 1991; Peitsch et al.,
1993; Shiokawa et al., 1994). Many agents including NO
synthase (NOS)-inducing agents have been shown to in-
 
duce activation of caspases, and apoptosis follows (Hale
et al., 1996).
NO is synthesized from arginine by NOS, generating cit-
rulline. The availability of arginine is one of the rate limit- 
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ing factors of cellular NO production. When the inducible
type NOS (iNOS) is induced, the activity is so high that the
supply of arginine is important. This amino acid can be ob-
tained from blood circulation, intracellular protein degra-
dation, or by regeneration from citrulline through the Òcit-
rulline-NO cycleÓ (Hecker et al., 1990; Hattori et al., 1994;
Nussler et al., 1994; Nagasaki et al., 1996). As arginine is a
common substrate for NOS and arginase, arginase may
compete with NOS for arginine, and downregulate pro-
duction of NO. Arginase exists in two known isoforms.
Liver-type arginase (arginase I) is expressed almost exclu-
sively in the liver and catalyzes the last step of urea synthe-
sis. However, we found that arginase I is highly induced in
rat macrophages activated with bacterial lipopolysaccha-
ride (LPS; Sonoki et al., 1997). On the other hand, nonhe-
patic type (arginase II) is expressed in some extrahepatic
tissues (Grody et al., 1989). Recently, we (Gotoh et al.,
1996) and others (Vockley et al., 1996; Morris et al., 1997)
cloned human arginase II cDNA and localized the argi-
nase II gene to chromosome 14q24.1-24.3 (Gotoh et al.,
1997). Activity (Wang et al., 1995) and mRNA (Gotoh
et al., 1996) of arginase II, as well as those of iNOS, are in-
duced by LPS in murine macrophage-like RAW 264.7
cells. On the other hand, treatment of RAW cells with
LPS and interferon-
 
g
 
 (IFN-
 
g
 
) induces apoptosis (Messmer
et al., 1996).
Here, we report that the LPS/IFN-
 
g
 
Ðdependent apopto-
sis of RAW cells is prevented by dexamethasone (Dex)
and cAMP, and that this antiapoptotic effect depends on
induction of arginase II that leads to suppression of iNOS-
dependent production of NO in these cells.
 
Materials and Methods
 
Plasmids
 
pCAGGS-rAI, a mammalian expression plasmid for rat arginase I, was
constructed by inserting the EcoRI-PstI fragment of pARGr-2 (Kawa-
moto et al., 1987) into the EcoRI site of the plasmid pCAGGS (Niwa et al.,
1991) after linker attachment. The rat arginase II cDNA clone was iso-
lated by PCR, using mRNA from the small intestine of a male Wistar rat.
PCR was carried out using rat arginase II primers corresponding to nucle-
otides 86Ð1211 (GenBank, accession number U90887). The obtained
product was inserted into the HincII site of pGEM-3Zf(
 
1
 
) (Promega
Corp.), yielding pGEM-rAII-2.
 
Materials
 
Antiserum against human arginase II was raised in a rabbit by injecting
 
Escherichia coli
 
Ðexpressed and the purified mature portion of human ar-
ginase II (residues 25Ð354). A monoclonal antibody against mouse iNOS
was obtained from Transduction Laboratories.
 
Cell Culture and DNA Transfection
 
Mouse macrophage-like RAW 264.7 cells were grown in EagleÕs minimal
essential medium supplemented with 10% fetal calf serum. Transfection
of RAW cells with plasmids was carried out using TransIT-LT1 Poly-
amine (PanVera Corp.) according to the protocol provided by the manu-
facturer.
 
Treatment of RAW Cells
 
RAW cells were cultured in medium with or without 1 
 
m
 
M Dex and/or 1 mM
dibutyryl cAMP for 24 h, and then treated with various combinations of 
 
E.
coli
 
 LPS (serotype 0127:B8, Sigma Chem. Co., 150 
 
m
 
g/ml) and mouse
IFN-
 
g
 
 (100 U/ml) for indicated periods. A NO scavenger carboxy-PTIO
[2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide, 300
 
m
 
M] or a NO donor SNAP (
 
S
 
-nitroso-
 
N
 
-acetyl-
 
DL
 
-penicillamine, 1 mM)
was added to the medium concomitantly with the addition of LPS and/or
IFN-
 
g
 
.
 
RNA Blot Analysis
 
Total RNA from RAW cells was prepared by the guanidium thiocyanate-
phenol-chloroform extraction procedure (Chomczynski and Sacchi, 1987).
After electrophoresis in formaldehyde-containing agarose gels, RNAs
were transferred to nylon membranes. Hybridization was performed using
digoxigenin-labeled antisense RNAs as probes for rat iNOS, or rat argi-
nase II. The antisense RNAs were synthesized using as templates
pcDNAII-riNOS (Nagasaki et al., 1996), or pGEM-rAII-2, digested by
appropriate restriction enzymes. Chemiluminescence signals derived from
hybridized probes were detected on x-ray films using DIG luminescence
detection kits (Boehringer Mannheim GmbH), and were quantified using
a MacBAS bio-image analyzer (Fuji Photo Film Co.).
 
Immunoblot Analysis
 
RAW cells were homogenized in 20 mM Hepes-KOH (pH 7.5) contain-
ing 1% Triton X-100, 20% glycerol, and 1 mM dithiothreitol. After cen-
trifugation, the supernatants were used as cell extracts for immunoblot
analysis. The cell extracts were subjected to SDS-polyacrylamide gel
electrophoresis, and proteins were electrotransferred to nitrocellulose
membranes. Immunodetection was performed using ECL kits (Nycomed
Amersham), according to the protocol provided by the manufacturer. The
results were quantified using a MacBAS bio-image analyzer.
 
Immunocytochemical Staining
 
RAW cells were cultured on coverslips and transfected with the human
arginase II expression plasmid or stimulated with LPS (150 
 
m
 
g/ml), Dex
(1 
 
m
 
M), and dibutyryl cAMP (1 mM), as described above. The cells were
fixed with 4% paraformaldehyde for 40 min at room temperature and
treated with phosphate-buffered saline containing 1% Triton X-100. The
cells were then incubated with antiserum against human arginase II and
then with goat antiÐrabbit IgG conjugated with FITC (Vector Laborato-
ries) as the second antibody. The stained cells were observed under a fluo-
rescence microscope.
 
Detection of Apoptosis
 
RAW cells were treated as described above. To analyze morphological
changes of nuclei, the cells were fixed, stained with 8 
 
m
 
g/ml of the Hoechst
dye 33258 for 5 min, and washed with phosphate-buffered saline. The
stained cells were observed under a fluorescence microscope. DNA frag-
mentation was detected by the terminal transferase-mediated dUTP-bio-
tin nick end labeling method (TUNEL method), using in situ apoptosis
detection kits (Takara) according to the protocol provided by the manu-
facturer. To detect DNA ladder formation, we used apoptosis ladder de-
tection kits (Wako Pure Chemical Industries) according to the protocol
provided by the manufacturer. DNA was isolated from the cells, resolved
on agarose gels, stained with SYBR Green I, and visualized by UV transil-
lumination.
 
Other Methods
 
Arginase activity was measured as described in Schimke (1962). Concen-
tration of NO
 
2
 
2
 
 plus NO
 
3
 
2
 
 in culture supernatants was measured using
the Griess reagent with the NO
 
2
 
/NO
 
3
 
 assay kit-C (Dojindo Labs) after re-
duction of NO
 
3
 
2
 
 to NO
 
2
 
2
 
 according to the protocol provided by the man-
ufacturer.
 
Results
 
LPS/IFN-
 
g
 
 Induces NO-mediated Apoptosis of
RAW Cells
 
When mouse macrophage-like RAW 264.7 cells were
treated with LPS/IFN-
 
g
 
 for 24 h, morphological changes
characteristic of apoptosis occurred (Fig. 1 A). Round-
shaped cells and apoptotic bodies were observed in phase- 
Gotoh and Mori 
 
Prevention of NO-mediated Apoptosis by Arginase
 
429
 
contrast images, and chromatin condensation and nucleus
fragmentation were seen in the case of Hoechst dye 33258
staining. Most cells were positive for TUNEL staining.
These apoptotic changes were strongly prevented by add-
ing a NO scavenger carboxy-PTIO (Akaike et al., 1993;
Fig. 1 B). These results show that LPS/IFN-
 
g
 
 induces apop-
tosis of RAW cells, and this apoptosis is mediated by NO.
LPS alone was much less effective in inducing apoptosis
(data not shown).
 
Induction of Arginase II Prevents iNOS-dependent 
Apoptosis of RAW Cells
 
NO is synthesized from arginine, a common substrate for
NOS and arginase. We reported that iNOS and arginase II
mRNAs are coinduced in RAW cells by LPS (Gotoh et al.,
1996). On the other hand, when these cells were treated
with LPS plus IFN-
 
g
 
, the induction of iNOS mRNA was
augmented, whereas the induction of arginase II was
strongly suppressed (Gotoh et al., 1996).
We then asked whether LPS/IFN-
 
g
 
Ðinduced apoptosis
would be prevented by arginase II induction. RAW cells
were cultured in the presence or absence of Dex/cAMP
for 24 h, and then treated with LPS or IFN-
 
g
 
, or their com-
bination for 6 or 12 h (Fig. 2 A). Fig. 2, B and C, shows ef-
fects of various combinations of reagents on iNOS and
arginase II mRNAs. iNOS mRNA of 
 
z
 
4.5 kb was not evi-
dent in the untreated cells but was induced by LPS, and
this induction was enhanced by IFN-
 
g
 
 or Dex/cAMP, and
even more strongly by their combination. Dex/cAMP was
without effect. Arginase II mRNA of 
 
z
 
1.8 kb that was low
in untreated cells was induced by LPS or Dex/cAMP and
even more so by their combination. IFN-
 
g
 
 strongly pre-
vented the induction of arginase II by LPS, whereas it had
little effect on the induction by LPS plus Dex/cAMP. In
other words, inhibition of LPS induction of arginase II
mRNA by IFN-
 
g
 
 was alleviated by Dex/cAMP. cAMP
alone had some effect in such cases, whereas Dex alone
was ineffective (Fig. 2 D).
Fig. 2, E and F, shows immunoblot analysis of arginase
II protein in RAW cells treated with Dex/cAMP for 24 h
and then with LPS and/or IFN-
 
g
 
 for 12 h. Arginase II pro-
tein was induced by LPS and this induction was prevented
by IFN-
 
g
 
. It was also induced by Dex/cAMP, and LPS plus
Dex/cAMP appeared to have an additive effect. The in-
duction of arginase II protein by LPS plus Dex/cAMP was
somewhat reduced by the further addition of IFN-
 
g
 
. The
results of arginase II protein were in accord with those of
arginase II mRNA (Fig. 2, B and C).
We then examined the effect of Dex and cAMP on LPS/
IFN-
 
g
 
Ðinduced apoptosis of RAW cells (Fig. 2 G). When
 
Figure 1.
 
Induction of NO-mediated apoptosis of RAW cells by
treatment with LPS and IFN-
 
g
 
. (A) RAW cells were cultured for
24 h with (dÐf) or without (aÐc) 150 
 
m
 
g/ml LPS and 100 U/ml
IFN-
 
g
 
. After fixation, the cells were analyzed for apoptosis by
the TUNEL method (b and e) or stained with a DNA-specific
fluorochrome Hoechst dye 33258 (c and f). Phase-contrast im-
ages (a and d) and fluorescence images (b and e) of the same
fields are shown. Original magnifications: a, b, d, and e, 
 
3
 
400; c
and f, 
 
3
 
1,000. Bars, 10 
 
m
 
m. When the cells were treated with
LPS/IFN-
 
g
 
, a portion of the cells was apparently dead and de-
tached from coverslips and the number of attached cells de-
creased. (B) RAW cells were cultured for 24 h with 150 
 
m
 
g/ml
LPS and 100 U/ml IFN-
 
g
 
. At the same time of the addition of
LPS/IFN-
 
g
 
, a NO scavenger carboxy-PTIO (300 
 
m
 
M) was added
to the medium where indicated. After fixation, the cells were an-
alyzed for apoptosis by the TUNEL method. Phase-contrast im-
ages (a and c) and fluorescence images (b and d) of the same
fields are shown. Original magnifications: 
 
3
 
400. Bars, 10 
 
m
 
m. 
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cells were treated with LPS/IFN-
 
g
 
, iNOS but not arginase
II was induced. Under these conditions, apoptotic changes
were observed. These changes were effectively prevented
by Dex/cAMP; under these conditions both iNOS and ar-
ginase II were induced. Dex or cAMP alone was much less
effective than their combination in arginase II induction in
the presence of LPS/IFN-
 
g
 
 (Fig. 2 D), and was not effec-
tive in preventing apoptosis.
Figure 2. Effect of induction of
arginase II on apoptosis of
RAW cells. (A) Time course
of treatment of RAW cells is
shown. RAW cells were cul-
tured in the medium with or
without 1 mM Dex and/or 1 mM
dibutyryl cAMP (cAMP) for
24 h, and then treated with vari-
ous combinations of LPS (150
mg/ml) and IFN-g (100 U/ml)
for 6 h for RNA blot analysis
(BÐD) or 12 h for immunoblot
analysis and apoptosis assays
(EÐH). (B) RAW cells were
treated with reagents as indi-
cated and total RNAs (2 mg)
were subjected to blot analysis
for iNOS and arginase II (AII)
mRNAs. The positions of 18S
and 28S rRNAs are shown on
the right. The bottom panels in
B show ethidium bromide stain-
ing of 18S and 28S rRNAs. (C)
The results in B were quanti-
tated and are shown by means 6
ranges (n 5 2). Maximal values
are set at 100%. (D) Experi-
ments were performed as in B
and the results for arginase II
(AII) mRNA were quantitated
and are shown by means 6 SE
(n 5 3). Maximal value is set at
100%. (E) RAW cells were
treated with reagents as indi-
cated on the top and the cell ex-
tracts (30 mg) were subjected to
immunoblot analysis for the ar-
ginase II (AII) protein. The mo-
lecular mass marker on the right
was ovalbumin (46 kD). (F) The results in E (n 5 2) and a parallel experiment (n 5 2) were quantitated and are shown by means 6 SE
(n 5 4). Maximal value is set at 100%. (G) RAW cells were cultured in the medium with or without 1 mM Dex and/or 1 mM dibutyryl
cAMP for 24 h, and then treated with LPS (150 mg/ml) and IFN-g (100 U/ml) for 12 h. After fixation, the cells were stained with Hoechst
dye 33258. Phase-contrast images (a, c, e, and g) and fluorescence images (b, d, f, and h) of the same fields are shown. Original magnifi-
cations: 3400. Bars, 10 mm. The percentage of total cells which were determined to be apoptotic is shown on the bottom of each panel.
(H) RAW cells were treated with reagents as indicated on the top. DNAs were isolated, resolved on an agarose gel, stained with SYBR
Green I, and visualized for DNA fragmentation by UV transillumination. 
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Fig. 2 H shows results of agarose gel electrophoresis of
DNA. The formation of a DNA ladder, characteristic of
apoptotic cells, was observed when the cells were treated
with LPS/IFN-
 
g
 
. This ladder formation was prevented by
Dex/cAMP. Dex or cAMP had little effect in preventing
ladder formation. All these results suggest strongly that
apoptosis is prevented by the induction of arginase II.
 
Transfection of Arginase Expression Plasmids Prevents 
iNOS-dependent Apoptosis of RAW Cells
 
To examine the effect of arginase on apoptosis even more
directly, transfection experiments were done. In a control
experiment, RAW cells were treated with LPS plus Dex/
cAMP to induce arginase II. After fixation, the cells were
immunostained with an antibody against arginase II (Fig.
3). Little immunoreactivity was observed in untreated
cells. On the other hand, when the cells were treated with
LPS plus Dex/cAMP, the cells became positive for ar-
ginase II immunoreactivity. Thread-like structures were
stained, results reflecting localization of arginase II in the
mitochondria (Gotoh et al., 1996). When the cells were
transiently transfected with the arginase II plasmid, some
cells that were apparently transfected with the plasmid were
strongly immunostained. Thread-like mitochondrial struc-
tures were visible in most of the positive cells, whereas
whole cells were stained in some positive cells, probably
due to a high overexpression of the enzyme.
Fig. 4 shows the effect of arginase II expression on apop-
tosis of RAW cells. Apoptotic changes were observed by
 
the addition of LPS/IFN-
 
g
 
. When the arginase II plasmid
was transfected, some cells were protected from apoptotic
change. Transfection of an expression plasmid for arginase
I, a cytosolic enzyme, was also effective in protecting cells
from LPS/IFN-
 
g
 
Ðdependent apoptosis. Transfection of the
insertless plasmid was without effect. These results sup-
port our hypothesis that arginase prevents apoptosis by
depleting intracellular arginine and thus decreasing pro-
duction of NO. Both mitochondrial arginase II and cytoso-
lic arginase I were effective.
To gain support for this hypothesis, we examined the ef-
fect of a NO donor SNAP on apoptosis of RAW cells.
SNAP alone induced apoptosis of the cells. SNAP also
canceled the antiapoptotic effects of Dex/cAMP or argi-
nase II plasmid (data not shown). Therefore, the antiapop-
totic effect of arginase relates to downregulation of NO
production by the enzyme. In fact, when a high concentra-
tion of arginine (12 mM) was added to the culture me-
dium, antiapoptotic effects of the arginase II plasmid were
not observed, and all the cells underwent apoptosis (data
not shown). 12 mM arginine alone induced no apoptotic
change of the cells.
 
Arginase II Suppresses NO Production in RAW Cells
 
We next examined the effect of arginase II induction on
NO production in RAW cells (Fig. 5). NO production
measured by NO
 
2
 
 plus NO
 
3
 
 in the culture medium was not
detected in untreated cells. When the cells were treated
with LPS/IFN-
 
g
 
, iNOS protein was induced and NO pro-
duction was markedly increased. On the other hand, when
Dex plus cAMP were included with LPS/IFN-
 
g
 
, iNOS pro-
tein was further induced, whereas arginase activity was
highly induced, and NO production was markedly de-
creased. These results suggest strongly that the induced ar-
ginase II competes with iNOS for arginine and suppresses
NO production.
 
Discussion
 
Arginine is a common substrate for NOS and arginase. In
RAW cells, LPS/IFN-
 
g
 
 treatment induces iNOS and NO-
mediated apoptosis. We obtained evidence that the in-
duced arginase downregulates NO production by deplet-
ing arginine and hence preventing apoptosis. First, when
arginase II was induced by Dex/cAMP in activated cells,
iNOS induction was not suppressed, but apoptosis was
prevented. Second, when the expression plasmid for argi-
nase I or II was transiently transfected, some cells were
prevented from apoptosis. Third, a NO donor or a high
concentration of arginine canceled out this antiapoptotic
effect of arginase. Fourth, NO production was suppressed
under conditions where the iNOS expression remained
high and arginase II was induced.
In cases of septic shock, iNOS is strongly induced and a
large amount of NO is produced. This high-output produc-
tion of NO is thought to lead to various symptoms, espe-
cially hypotension (Moncada and Higgs, 1993). Glucocor-
ticoids and epinephrine are prescribed in cases of shock
state. There are reports that glucocorticoids inhibit NF-
 
kB
activity through the induction of IkB synthesis (Auphan
et al., 1995; Scheinman et al., 1995) and suppress expres-
Figure 3. Immunocytostaining of arginase II in RAW cells.
RAW cells were treated with LPS (150 mg/ml), 1 mM Dex, and
1 mM dibutyryl cAMP for 24 h to induce arginase II (B and C),
or transfected with human arginase II expression plasmid
pCAGGS-hAII and cultured for 36 h (D and E). The cells were
then fixed and immunostained with rabbit antiserum against argi-
nase II, as described in Materials and Methods. A is an untreated
control. Original magnifications: A, B, and D, 3400; C and E,
31000. Bars, 10 mm.The Journal of Cell Biology, Volume 144, 1999 432
sion of inflammatory genes, including the iNOS gene. Our
present results suggest that the combination of Dex, a syn-
thetic glucocorticoid, and cAMP, a second messenger of
epinephrine, may also contribute to the antishock effect by
inducing arginase II and downregulating NO production.
If such is the case, arginase would be a good target for
therapy of septic shock and other conditions due to the
overexpression of NO. NOS inhibitors usually inhibit all
types of NOS and inhibition of constitutive types of NOS
may cause side effects. On the other hand, the demand of
iNOS for its substrate arginine is much higher than those
of constitutive NOSs because of its very high activity. The
induction of arginase may lead to selective inhibition of
the high output NO production by iNOS.
We reported that iNOS and arginase I, not arginase II,
are coinduced by LPS in cultured rat peritoneal macro-
phages and in the lung and spleen in vivo (Sonoki et al.,
1997). The induction of arginase I is slower than that of
iNOS. Based on these findings, we suggested that iNOS is
first induced, NO is produced, and then arginase is in-
duced and the sustained overproduction of NO that is
toxic to surrounding cells is prevented. In rat aortic endo-
thelial cells, both constitutive and LPS-inducible arginase
activity were reported to be present (Buga et al., 1996).
The constitutive presence of arginase I and induction of
arginase II by LPS were evident, as determined using
immunoprecipitation experiments. iNOS is known to be
highly induced in rat hepatocytes by the combination of
tumor necrosis factor, IL-1, IFN-g, and LPS (Geller et al.,
1993). Treatment of rats with glucocorticoids and cAMP
induces arginase I in hepatocytes (Morris et al., 1987). It
remains to be seen whether expression of arginase I is af-
fected by treatment with LPS in combination with gluco-
corticoids and cAMP.
Induction of arginase I and II differs between rats and
mice. As reported previously (Sonoki et al., 1997) and as
mentioned above, only arginase I is induced by LPS in rat
peritoneal macrophages and in the lung and spleen in vivo.
On the other hand, only arginase II is induced in mouse
macrophage-like RAW cells (Wang et al., 1995; Gotoh et al.,
1996). Thus, there appears to be a differential regulation
of expression of these two isoforms in various cell types in
Figure 4. Effect of transfection
of arginase expression plasmids.
RAW cells were transfected
with insertless pCAGGS (e and
f), human arginase II expression
plasmid pCAGGS-hAII (gÐj), or
rat arginase I expression plasmid
pCAGGS-rAI (k and l). 24 h af-
ter transfection, LPS (150 mg/ml)
and IFN-g (100 U/ml) were
added to the medium and cul-
tured for 12 h. The cells were
then fixed and stained with
Hoechst dye 33258 except i and j
that were analyzed for apoptosis
by the TUNEL method after fix-
ation. Phase-contrast images (a,
c, e, g, i, and k) and fluorescence
images (b, d, f, h, j, and l) of the
same fields are shown. Original
magnifications:  3400. Bars, 10
mm. A portion of the cells was
detached from coverslips by
treatment with LPS/IFN-g (cÐl).
Arrows indicate cells rescued
from apoptosis. The percentage
of total cells which were deter-
mined to be apoptotic is shown
on the bottom of each panel.Gotoh and Mori Prevention of NO-mediated Apoptosis by Arginase 433
various species. Despite this, our results show both forms
are effective in preventing NO-mediated apoptosis.
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